In breast cancer cohorts (TCGA, METABRIC; n = 1,986), TET1 expression positively correlated with genes in the SMAD/TGF-β pathway, particularly SMAD4 (P < 0.05; Fig. 4A). This evidence concerns the gene SMAD4 and breast carcinoma.